<p>Robert Jacks has 20 years of experience in the biopharmaceutical industry. He has founded or co-founded multiple companies and raised more than $170 million with several successful exits.

He is now the President &amp; CEO of Sparrow Pharmaceuticals which is developing targeted therapies for serious disorders of steroid excess and raised a $50M Series A in 2021. 

</p>

Making Leave Not Suck: Jennifer Henderson, CEO & Founder of Tilt

Tune in as Matt uncovers the inspiring stories, lessons, and advice on how to make it at the highest level from top executives, entrepreneurs, founders, thought leaders, and investors. 

Conversations include a wide range of topics and conversations including career advice, industry trends and challenges, failing forward, and incredible stories of perseverance and overcoming the odds especially in the arenas of tech, life sciences, finance, and more.